Politico reports that congressional leaders have a growing to-do list for healthcare and a "narrow" window to make progress before the 2020 election.
Leaders in both chambers are optimistic they can find common ground on surprise medical billing legislation by May, according to the report.
The outlook is less sunny for drug pricing legislation, which faces a steeper climb to approval. A bipartisan proposal in the Senate hasn't gained traction due to a provision that would fine pharmaceutical companies for increasing drug prices faster than inflation. Democrats and Republicans in the House are at odds over allowing Medicare to directly negotiate drug prices, according to the report.
Other items on the docket include:
- Results of a probe into short-term health insurance policies and their marketing practices
- Continued investigation of CMS Administrator Seema Verma's use of private contractors
- Investigation of state use of opioid funding
For the full story, click here.
More articles on leadership and management:
Brad Smith to head CMS innovation center
How the White House affects corporate social responsibility
Healthcare bureaucracy cost $812B in 2017